L Edvinsson Selected Research

L Edvinsson Research Topics

Disease

16	Migraine Disorders (Migraine) 09/2021 - 03/2001
15	Headache (Headaches) 09/2010 - 01/2000
7	Cluster Headache (Cluster Headaches) 06/2002 - 01/2000
6	Stroke (Strokes) 01/2018 - 12/2006
5	Inflammation (Inflammations) 12/2016 - 12/2003
5	Rhinorrhea 09/2001 - 01/2000
4	Heart Failure 12/2003 - 01/2000
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2002 - 02/2000
3	Infarction (Infarctions) 01/2018 - 05/2006
2	Pain (Aches) 09/2021 - 03/2001
2	Ischemic Stroke 01/2018 - 01/2017
2	Ganglion Cysts (Ganglion) 01/2012 - 05/2001
2	Atherosclerosis 11/2011 - 09/2000
2	Hypertension (High Blood Pressure) 01/2002 - 01/2000
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018
1	Necrosis 06/2012
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 11/2011
1	Reperfusion Injury 05/2006
1	Post-Traumatic Headache 09/2005
1	Hypotension (Low Blood Pressure) 01/2005
1	Neoplasms (Cancer) 04/2002
1	Paroxysmal Hemicrania (Chronic Paroxysmal Hemicrania) 09/2001
1	Hyperventilation 06/2001
1	Acute Liver Failure (Fulminant Hepatic Failure) 06/2001

Drug/Important Bio-Agent (IBA)

16	Calcitonin Gene-Related PeptideIBA 09/2021 - 01/2000
11	NeuropeptidesIBA 09/2021 - 01/2000
8	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2012 - 01/2000
6	Tryptamines (Triptans)IBA 08/2004 - 01/2001
5	Sumatriptan (Imigran)FDA LinkGeneric 04/2010 - 01/2000
4	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 09/2021 - 08/2004
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2010 - 05/2006
3	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 09/2021 - 08/2004
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2000
3	Peptides (Polypeptides)IBA 01/2012 - 03/2001
3	Neuropeptide YIBA 04/2010 - 01/2000
3	Messenger RNA (mRNA)IBA 12/2006 - 04/2002
3	Adenosine Triphosphate (ATP)IBA 09/2000 - 01/2000
2	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 01/2018 - 01/2017
2	U 0126 (UO 126)IBA 01/2018 - 01/2017
2	Angiotensin IIIBA 02/2015 - 11/2011
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2015 - 01/2000
2	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2012 - 05/2001
2	Pharmaceutical PreparationsIBA 10/2007 - 03/2001
2	Endothelin-1 (Endothelin 1)IBA 05/2006 - 02/2000
2	Vasodilator Agents (Vasodilators)IBA 01/2002 - 03/2001
2	Serotonin (5 Hydroxytryptamine)IBA 08/2001 - 06/2001
1	ubrogepantIBA 09/2021
1	rimegepant sulfateIBA 09/2021
1	Monoclonal AntibodiesIBA 09/2021
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	NestinIBA 01/2017
1	Freund's AdjuvantIBA 12/2016
1	AldosteroneIBA 02/2015
1	Angiotensin IIBA 02/2015
1	Epinephrine (Adrenaline)FDA LinkGeneric 02/2015
1	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2015
1	ReninIBA 02/2015
1	Neuroprotective AgentsIBA 02/2015
1	Type 1 Angiotensin ReceptorIBA 02/2015
1	Kynurenic Acid (Kynurenate)IBA 01/2015
1	SmokeIBA 01/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2012
1	CytokinesIBA 06/2012
1	Platelet-Derived Growth FactorIBA 06/2012
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 06/2012
1	Endothelin Receptors (Endothelin Receptor)IBA 06/2012
1	Epidermal Growth Factor (EGF)IBA 06/2012
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2012
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2012
1	AngiotensinsIBA 11/2011
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2011
1	Vasoconstrictor AgentsIBA 09/2011
1	Nitroglycerin (Dynamite)FDA LinkGeneric 04/2010
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2010
1	biotinylated dextran amine (B-DA)IBA 09/2009
1	Glycerol (Glycerine)FDA LinkGeneric 12/2008
1	PPAR alphaIBA 05/2006
1	LigandsIBA 05/2006
1	Biomarkers (Surrogate Marker)IBA 09/2005
1	Carbon DioxideIBA 01/2005
1	LDL CholesterolIBA 12/2003
1	HomocysteineIBA 12/2003
1	von Willebrand FactorIBA 12/2003
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2003
1	Blood Glucose (Blood Sugar)IBA 12/2003
1	Substance PIBA 07/2002
1	Adenosine A1 ReceptorIBA 06/2002
1	Endothelins (Endothelin)IBA 06/2001
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 05/2001
1	4991W93IBA 03/2001
1	Blood Proteins (Serum Proteins)IBA 03/2001
1	zolmitriptan (Zomig)FDA Link 03/2001
1	salicylhydroxamic acid (SHAM)IBA 01/2001
1	SolutionsIBA 01/2001

Therapy/Procedure

5	Therapeutics 09/2021 - 08/2001
1	Intravenous Infusions 04/2010
1	Denervation 05/2001